ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,652.08
      1.32%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kazia Therapeutics Ltd (KZIA)

      7. Kazia Therapeutics Ltd (KZIA) News

      KZIA

      Kazia Therapeutics (KZIA)

      Kazia Therapeutics Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KZIA
      DateTimeSourceHeadlineSymbolCompany
      10/29/20186:18AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/29/20186:00AMPR Newswire (US)Progress Update on GDC-0084 ProgramNASDAQ:KZIAKazia Therapeutics Ltd
      10/29/20186:00AMPR Newswire (US)Progress Update on GDC-0084 ProgramNASDAQ:KZIAKazia Therapeutics Ltd
      10/24/20187:25AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:KZIAKazia Therapeutics Ltd
      10/24/20186:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/22/20186:14AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/22/20186:00AMPR Newswire (US)Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast CancerNASDAQ:KZIAKazia Therapeutics Ltd
      10/22/20186:00AMPR Newswire (US)Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast CancerNASDAQ:KZIAKazia Therapeutics Ltd
      10/19/20186:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/17/20189:24PMPR Newswire (US)Kazia Raises A$3.4 Million to Progress R&D ProgramsNASDAQ:KZIAKazia Therapeutics Ltd
      10/11/20186:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/10/201810:00AMPR Newswire (US)Cantrixil Phase I Study Progresses To Next StageNASDAQ:KZIAKazia Therapeutics Ltd
      10/10/20186:18AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/10/20185:00AMPR Newswire (US)Cantrixil Phase I Study Progresses To Next StageNASDAQ:KZIAKazia Therapeutics Ltd
      10/09/20186:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/03/20186:11AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/01/20185:07PMPR Newswire (US)John Theurer Cancer Center Enrolls First Two Patients Nationwide for Groundbreaking Phase II Clinical Trial for GlioblastomaNASDAQ:KZIAKazia Therapeutics Ltd
      09/17/20187:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      08/31/20186:19AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KZIAKazia Therapeutics Ltd
      08/23/20186:23AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:KZIAKazia Therapeutics Ltd
      07/19/20186:11AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:KZIAKazia Therapeutics Ltd
      07/18/20186:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      07/13/20186:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      06/25/20187:57AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      06/21/20186:17AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      06/19/20186:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      06/19/20186:00AMPR Newswire (US)Kazia Releases Preliminary Cantrixil Phase I DataNASDAQ:KZIAKazia Therapeutics Ltd
      05/21/20186:29AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      03/29/20186:14AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      03/28/20188:23PMPR Newswire (US)Commencement Of Phase II Clinical Study Of GDC-0084NASDAQ:KZIAKazia Therapeutics Ltd
       Showing the most relevant articles for your search:NASDAQ:KZIA